All-oral therapy with nucleotide inhibitors sofosbuvir and GS-0938 for 14 days in treatment-naive genotype 1 hepatitis C (NUCLEAR)
- E. J. Lawitz
- , M. Rodriguez-Torres
- , J. Denning
- , A. Mathias
- , H. Mo
- , B. Gao
- , M. T. Cornpropst
- , M. M. Berrey
- , W. T. Symonds
Research output: Contribution to journal › Article › peer-review
25
Link opens in a new tab
Scopus
citations